Startups
Xcenda’s strategic consulting and field reimbursement services help pharmaceutical and biotech manufacturers thrive in global, value-driven healthcare markets. Our areas of expertise include health economics and outcomes research, reimbursement and global market access strategy, market research, and health policy analysis, as well as the development of value demonstration tools, scientific publications, training programs and outsourced field reimbursement teams. We apply a broad, yet strategically connected array of consulting services to help manufacturers identify, demonstrate, and deliver their brand’s value proposition to key healthcare stakeholders.
Overview
Location
United States, South Carolina, Fort Mill
Employees
501-1000
Phone
+1 800-320-6497
Founded date
1994
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 26, 2022 | Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill | More than 500 stakeholders sent comments to the FTC on whether the commission should look further into pharma middlemen, known as PBMs, with many of the commenters calling for more federal oversight. Similar to the critic... |
| Dec 3, 2021 | Massachusetts Legislature Proposes Banning Use Of Cost-Effectiveness Analysis To Inform Healthcare Coverage Decisions | Highway Signpost "Cost-Effectiveness Analysis"getty |
| Sep 3, 2021 | Incorporating The Patient’s Voice In Value Assessment And Decision-Making Regarding Use Of Medical Technologies | A young female hospital patient lies in bed while attached to a medical transfusion device in a ... [+] London medical clinic. Corbis via Getty Images |
| Apr 8, 2021 | Xcenda's FormularyDecisions Launches Resource Hub for Biosimilar Products | As the demand for biosimilar product information continues to grow among payers, Xcenda’s FormularyDecisions—a secure online platform that facilitates information exchange between manufacturers and healthcare decision-makers—announced today... |
| Jan 13, 2015 | Modell Foundation launches software it says can save $40B with early detection of primary immunodeficiency | “The problem is it’s undiagnosed with 90 percent of patients who get this,” said Vicki Modell, who with her wife husband, Fred, started the foundation in honor of their son Jeffrey, who died at 15 from a primary immunodeficiency. Some three... |
| Modell Foundation launches software it says can save $40B with early detection of primary immunodeficiency | The Jeffrey Modell Foundation in New York recently launched software that aims to better inform the healthcare world on primary immunodeficiency disorders, harnessing data from medical records that could significantly improve early detectio... | |
| For life sciences companies, data is key for continued innovation | Denise Juliano, group vice president, PINC AI™ Applied Sciences, Premier Inc. Recently, there has been a large boom in the use of real-world data (RWD) and real-world evidence (RWE), which is expected to become a $2.3 billion market by 2026... |
Reviews 0
FAQ about Xcenda
When was Xcenda founded?
Xcenda was founded in 1994.
What has the press written about Xcenda?
Parsers VC has collected 8 articles mentioning Xcenda, among them “Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill” (May 26, 2022) and “Massachusetts Legislature Proposes Banning Use Of Cost-Effectiveness Analysis To Inform Healthcare Coverage Decisions” (Dec 3, 2021).
Is Xcenda still active?
Yes, Xcenda is active; its latest activity on Parsers VC dates from Aug 30, 2022.